Selvas Ai Inc. (108860) - Total Liabilities
Based on the latest financial reports, Selvas Ai Inc. (108860) has total liabilities worth ₩50.35 Billion KRW (≈ $34.12 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Selvas Ai Inc. - Total Liabilities Trend (2011–2024)
This chart illustrates how Selvas Ai Inc.'s total liabilities have evolved over time, based on quarterly financial data. See 108860 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Selvas Ai Inc. Competitors by Total Liabilities
The table below lists competitors of Selvas Ai Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Forte Biosciences Inc
NASDAQ:FBRX
|
USA | $12.99 Million |
|
Vizsla Royalties Corp.
V:VROY
|
Canada | CA$499.70K |
|
LIWANLI Innovation Co Ltd
TW:3054
|
Taiwan | NT$32.86 Million |
|
Iris Acquisition Corp II
NYSE:IRAB
|
USA | $7.43 Million |
|
Harmony Electronics
TWO:8182
|
Taiwan | NT$2.25 Billion |
|
Bluerock Acquisition Corp. Class A Ordinary Shares
NASDAQ:BLRK
|
USA | $596.17K |
|
Galectin Therapeutics Inc
NASDAQ:GALT
|
USA | $146.00 Million |
|
ADF Group Inc.
TO:DRX
|
Canada | CA$150.82 Million |
Liability Composition Analysis (2011–2024)
This chart breaks down Selvas Ai Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Selvas Ai Inc. (108860) market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.30 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.43 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.16 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Selvas Ai Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Selvas Ai Inc. (2011–2024)
The table below shows the annual total liabilities of Selvas Ai Inc. from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩49.22 Billion ≈ $33.36 Million |
+102.81% |
| 2023-12-31 | ₩24.27 Billion ≈ $16.45 Million |
-53.37% |
| 2022-12-31 | ₩52.06 Billion ≈ $35.28 Million |
-8.88% |
| 2021-12-31 | ₩57.13 Billion ≈ $38.71 Million |
+2.66% |
| 2020-12-31 | ₩55.65 Billion ≈ $37.71 Million |
-12.63% |
| 2019-12-31 | ₩63.69 Billion ≈ $43.16 Million |
-4.28% |
| 2018-12-31 | ₩66.53 Billion ≈ $45.09 Million |
+8.69% |
| 2017-12-31 | ₩61.21 Billion ≈ $41.48 Million |
+15.29% |
| 2016-12-31 | ₩53.10 Billion ≈ $35.98 Million |
+62.82% |
| 2015-12-31 | ₩32.61 Billion ≈ $22.10 Million |
+364.92% |
| 2014-12-31 | ₩7.01 Billion ≈ $4.75 Million |
+27.48% |
| 2011-12-31 | ₩5.50 Billion ≈ $3.73 Million |
-- |
About Selvas Ai Inc.
Selvas AI Inc. operates as an artificial intelligence (AI) company in South Korea. The company offers Selvy Note, an AI Voice Record for recognizing the content of conversations such as research, consultation, and meetings; Selvy MediVoice, an AI medical voice recognition that generates medical records during the medical process through voice; Selvy SpeechEdu, an AI training voice recognition for… Read more